Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Sex-specific GWAS meta-analysis of anxiety from UK Biobank and All of Us (455,487 participants): 21 lead SNPs in females vs 5 in males. Between-sex genetic correlation was high but below one, and SNP heritability was higher in females.
Meta-analysisn = 455,487
Hu et al. Unravelling sex differences in the genetic architecture of anxietySystematic review of 12 studies (9 meta-analysed; 115,528 women) in premenopausal early-stage endometrial carcinoma: ovarian preservation vs BSO was associated with lower all-cause death (HR 0.805, 95% CI 0.655-0.989), with no clear difference in cancer death or recurrence.
Meta-analysisn = 115,528 women
Raffone et al. Impact of ovarian preservation on survival for premenopausal women with early-stage endometrial carcinoma: A systematic review and meta-analysisSystematic review and meta-analysis of 39 cohorts (95,037 adults) after out-of-hospital cardiac arrest: 11 prediction models had pooled AUROCs of 0.75–0.88 for poor functional outcome, with substantial heterogeneity; CAHP ≥150 gave 81.3% sensitivity, 77.0% specificity.
Meta-analysisn = 95,037
Niznick et al. Clinical Prediction Models for Prognostication After Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-AnalysisMeta-epidemiological review of 73 placebo-controlled RCTs (33,956 RA patients) of targeted therapies: physician global assessment improved slightly more than patient assessment (SMD -0.60 vs -0.50), mainly via swollen joint count; pain related only to patient assessment.
Meta-analysisn = 33,956
Lage-Hansen et al. Understanding patient and physician global assessments in rheumatoid arthritis: A meta-epidemiological study of core outcome set performanceMeta-analysis of 45 RCTs (32,215 critically ill adults on insulin infusions): intensive vs conventional glucose targets showed no difference in hospital or ICU mortality, with lower ICU stay, infections and polyneuropathy but 3.6-fold higher severe hypoglycaemia risk.
Meta-analysisn = 32,215
Sirimaturos et al. Comparison of Intensive Versus Conventional Glycemic Control Targets: An Updated Systematic Review and Meta-Analysis of the 2024 Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill AdultsSystematic review and meta-analysis of 55 studies (31,915 prepubertal boys): pooled mean stretched penile length was 3.07 cm at 1 week to 5.43 cm at 5–10 years, with significant regional variation over age 2 and a possible 16–26% decline from the 2000s to 2020s.
Meta-analysisn = 31,915
Negri et al. Paediatric penile length: a systematic review and meta-analysisSystematic review and meta-analysis of 80 studies (21,645 patients with lung cancer) found radiation dose to the whole heart and its substructures associated with cardiac events and survival; e.g. LAD V15 with MACE and mean heart dose with survival.
Meta-analysisn = 21,645
Li et al. Dosimetric Parameters of the Heart and Its Substructures in Predicting Cardiac Events or Survival in Patients With Lung Cancer After Radiation Therapy: A Systematic Review and Meta-analysisIn a systematic review of 16 studies (15,924 allo-HSCT recipients) with meta-analysis, chronic GVHD (RR 4.01, 95% CI 1.91–8.39), malignant primary diagnosis (RR 0.40) and myeloablative conditioning (RR 0.41) were reported as risk factors for secondary oral SCC.
Meta-analysisn = 15,924
Huang et al. A Systematic Review and Meta-Analysis of Risk Factors for Secondary Oral Squamous Cell Carcinoma After Allogeneic Hematopoietic Stem Cell TransplantationIn a systematic review and meta-analysis (37 studies, 12,629 people with SARS-CoV-2), pooled seroprevalence of anti-IFNα and/or anti-IFNω auto-antibodies was 14% (neutralising 12%) vs <1% anti-IFNα in healthy controls; heterogeneity was high and other infections lacked data.
Meta-analysisn = 12,629
Hill et al. Systematic Review and Meta-analysis of Anti-interferon Auto-antibodies in Infectious DiseasesMeta-analysis of 104 trials (10 353 patients) of CD3-based T cell-engaging bispecific antibodies: grade ≥3 treatment-related adverse events 70·3% in haematological cancers vs 45·3% in solid tumours; cytokine release syndrome most common; 1·0% treatment-related deaths.
Meta-analysisn = 10,353
Zhu et al. Treatment-related adverse events of CD3-based T cell-engaging bispecific antibodies in patients with cancer: a meta-analysis of clinical trials